Autor: |
Op de Hoek LJ; Leids Universitair Medisch Centrum, Leiden. Afd. Trombose & Hemostase., Montero Cabezas JM; Leids Universitair Medisch Centrum, Leiden. Afd. Hartziekten., den Exter PL; Leids Universitair Medisch Centrum, Leiden. Afd. Trombose & Hemostase., Al Amri I; Leids Universitair Medisch Centrum, Leiden. Afd. Hartziekten., Elzo Kraemer CV; Leids Universitair Medisch Centrum, Leiden. Afd. Intensive Care., Klok FA; Leids Universitair Medisch Centrum, Leiden. Afd. Trombose & Hemostase.; Contact: f.a.klok@lumc.nl. |
Jazyk: |
Dutch; Flemish |
Zdroj: |
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2024 Dec 23; Vol. 168. Date of Electronic Publication: 2024 Dec 23. |
Abstrakt: |
Treatment options for patients with severe pulmonary embolism (PE) have increased substantially over the past decade. Although systemic thrombolysis is still the reperfusion therapy of choice for hemodynamically unstable PE patients, several new catheter guided reperfusion therapies have emerged as possibly safer alternatives. These therapies are increasingly implemented in clinical practice even though their efficacy and safety are yet to be proven by clinical outcome studies. Along with the rise of new interventional therapies has come the introduction of multidisciplinary Pulmonary Embolism Response Teams (EXPERT-PE, referred to as PERT in the United States), composed of multidisciplinary experts involved in treating acute PE. The EXPERT-PE concept provides a multidisciplinary and rapid platform for deciding on an individualized treatment strategy in an era of rapidly developing advanced treatment options, combining expert opinion from all involved specialties and forming the base for future research in PE care. |
Databáze: |
MEDLINE |
Externí odkaz: |
|